D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 1.63 THB 0.62% Market Closed
Market Cap: 734.2m THB
Section:
 

Relative Value

The Relative Value of one DOD stock under the Base Case scenario is 1.53 THB. Compared to the current market price of 1.63 THB, DOD Biotech PCL is Overvalued by 6%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DOD Relative Value
Base Case
1.53 THB
Overvaluation 6%
Relative Value
Price
D
Worst Case
Base Case
Best Case

Valuation Multiples

1.2
P/S
P/S
Price to Sales
1.2
vs History
84
vs Industry
50
Median 3Y
1.7
Median 5Y
3
Industry
1
More Details
14.4
P/E
P/E
Price to Earnings
14.4
vs History
50
vs Industry
16
Median 3Y
-4.3
Median 5Y
14.6
Industry
17.7
More Details
7.2
P/OCF
P/OCF
Price to OCF
7.2
vs History
69
vs Industry
24
Median 3Y
10.8
Median 5Y
15.5
Industry
11.7
More Details
26.6
P/FCFE
P/FCFE
Price to FCFE
26.6
vs History
25
vs Industry
0
Median 3Y
-14.6
Median 5Y
-10.9
Industry
15.6
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
92
vs Industry
70
Median 3Y
1.2
Median 5Y
1.6
Industry
1.5
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
92
vs Industry
66
Median 3Y
1.7
Median 5Y
3.2
Industry
1.2
More Details
2.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.4
vs History
92
vs Industry
65
Median 3Y
4.8
Median 5Y
8.9
Industry
4
More Details
6.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.1
vs History
61
vs Industry
60
Median 3Y
4.4
Median 5Y
9.1
Industry
10.4
More Details
12.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.3
vs History
50
vs Industry
45
Median 3Y
-2.4
Median 5Y
12
Industry
13.5
More Details
5.1
EV/OCF
EV/OCF
Enterprise Value to OCF
5.1
vs History
69
vs Industry
35
Median 3Y
7.8
Median 5Y
13.4
Industry
12.5
More Details
11.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11.2
vs History
55
vs Industry
14
Median 3Y
12.2
Median 5Y
17.6
Industry
15.6
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
90
vs Industry
76
Median 3Y
1
Median 5Y
1.5
Industry
1.2
More Details

Multiples Across Competitors

DOD Competitors Multiples
DOD Biotech PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
DOD Biotech PCL
SET:DOD
734.2m THB 1.2 14.4 6.1 12.3
FR
L'Oreal SA
PAR:OR
193.9B EUR 4.4 31.7 18.4 22.4
UK
Unilever PLC
LSE:ULVR
118.6B GBP 2.2 23.7 202 234.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 8.4 49.4 35.8 39.6
UK
HALEON PLC
LSE:HLN
33.4B GBP 3 23.2 14 15.9
US
Estee Lauder Companies Inc
NYSE:EL
38.8B USD 2.7 -41.7 21.1 34.8
DE
Beiersdorf AG
XETRA:BEI
20.4B EUR 2.1 23.1 11.4 14.5
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.9 11.4 17.5
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 8.3 67.4 41.9 45.9
IN
Dabur India Ltd
NSE:DABUR
862.5B INR 6.8 47.7 35.7 44.3
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
TH
D
DOD Biotech PCL
SET:DOD
Average P/E: 33.8
14.4
N/A N/A
FR
L'Oreal SA
PAR:OR
31.7
8%
4
UK
Unilever PLC
LSE:ULVR
23.7
15%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
49.4
8%
6.2
UK
HALEON PLC
LSE:HLN
23.2
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -41.7 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.1
8%
2.9
JP
Kao Corp
TSE:4452
23.9
13%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
67.4
19%
3.5
IN
Dabur India Ltd
NSE:DABUR
47.7
12%
4
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
D
DOD Biotech PCL
SET:DOD
Average EV/EBITDA: 39.8
6.1
N/A N/A
FR
L'Oreal SA
PAR:OR
18.4
5%
3.7
UK
Unilever PLC
LSE:ULVR
202
1%
202
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
35.8
8%
4.5
UK
HALEON PLC
LSE:HLN
14
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
21.1
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.4
-1%
N/A
JP
Kao Corp
TSE:4452
11.4
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
41.9
13%
3.2
IN
Dabur India Ltd
NSE:DABUR
35.7
11%
3.2
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TH
D
DOD Biotech PCL
SET:DOD
Average EV/EBIT: 48.2
12.3
N/A N/A
FR
L'Oreal SA
PAR:OR
22.4
6%
3.7
UK
Unilever PLC
LSE:ULVR
234.7
1%
234.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.6
9%
4.4
UK
HALEON PLC
LSE:HLN
15.9
4%
4
US
Estee Lauder Companies Inc
NYSE:EL
34.8
25%
1.4
DE
Beiersdorf AG
XETRA:BEI
14.5
-2%
N/A
JP
Kao Corp
TSE:4452
17.5
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
45.9
13%
3.5
IN
Dabur India Ltd
NSE:DABUR
44.3
11%
4
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
DOD intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOD stock valuation using valuation multiples.
Wall Street Estimates
DOD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 305,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.